Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Structural Heart Disease: Newer heart valves & aortic angulation | TMVR for AMI patients | LAAO during cardiac surgery
Tuesday, June 22, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Structural Heart Disease

TEER with MitraClip XTR leads to consistent TR reduction, outperforming older devices

Researchers reported a technical success rate of 100%, but they did urge caution if the patient's coaptation gap size exceeds 8.4 mm. 

READ MORE >
patient with heart doctor
Share on Twitter Share on Facebook Share on Linkedin

TEER with MitraClip XTR leads to consistent TR reduction, outperforming older devices

Share on Twitter Share on Facebook Share on Linkedin
patient with heart doctor
Researchers reported a technical success rate of 100%, but they did urge caution if the patient's coaptation gap size exceeds 8.4 mm. 
READ MORE >

Thanks to newer heart valves, aortic angulation no longer affects TAVR outcomes

With older heart valves, a higher degree of aortic angulation was often associated with post-TAVR complications. 

READ MORE >
family visits with doctor
Share on Twitter Share on Facebook Share on Linkedin

Thanks to newer heart valves, aortic angulation no longer affects TAVR outcomes

Share on Twitter Share on Facebook Share on Linkedin
family visits with doctor
With older heart valves, a higher degree of aortic angulation was often associated with post-TAVR complications. 
READ MORE >

Surgery still more common than TMVR among AMI patients, but the gap is shrinking

The study's authors emphasized how important it is for clinicians to work together to determine the best treatment strategy. 

READ MORE >
With advances and increased experience in the percutaneous coronary intervention (PCI), same-day discharge (SDD) has become increasingly commonplace, but patient selection is key. Antithrombotic therapy may not be necessary for certain transcatheter aortic valve replacement (TAVR) patients, according to a new analysis published in JACC: Cardiovascular Interventions.
Share on Twitter Share on Facebook Share on Linkedin

Surgery still more common than TMVR among AMI patients, but the gap is shrinking

Share on Twitter Share on Facebook Share on Linkedin
With advances and increased experience in the percutaneous coronary intervention (PCI), same-day discharge (SDD) has become increasingly commonplace, but patient selection is key. Antithrombotic therapy may not be necessary for certain transcatheter aortic valve replacement (TAVR) patients, according to a new analysis published in JACC: Cardiovascular Interventions.
The study's authors emphasized how important it is for clinicians to work together to determine the best treatment strategy. 
READ MORE >

Abbott gains key approvals for new steerable delivery sheath

The new device was designed to treat LAA occlusion or closure patients with atrial fibrillation who face a high risk of stroke.

READ MORE >
approved approval safe
Share on Twitter Share on Facebook Share on Linkedin

Abbott gains key approvals for new steerable delivery sheath

Share on Twitter Share on Facebook Share on Linkedin
approved approval safe
The new device was designed to treat LAA occlusion or closure patients with atrial fibrillation who face a high risk of stroke.
READ MORE >

LAAO during cardiac surgery helps AFib patients reduce stroke risk

AFib patients undergoing cardiac surgery may benefit from concomitant LAAO, according to a new study in the New England Journal of Medicine.

READ MORE >
New research presented at the 103rd Annual Meeting of the American Association for Thoracic Surgery examined the lack of diversity seen among this important specialty. 
Share on Twitter Share on Facebook Share on Linkedin

LAAO during cardiac surgery helps AFib patients reduce stroke risk

Share on Twitter Share on Facebook Share on Linkedin
New research presented at the 103rd Annual Meeting of the American Association for Thoracic Surgery examined the lack of diversity seen among this important specialty. 
AFib patients undergoing cardiac surgery may benefit from concomitant LAAO, according to a new study in the New England Journal of Medicine.
READ MORE >

LAAC patients with major bleeding face worse outcomes, longer lengths of stay

The study, published in the American Journal of Cardiology, included data from nearly 20,000 patients treated in 2016 and 2017. 

READ MORE >
IVUS guidance during DES implantation boosts long-term outcomes in new study
Share on Twitter Share on Facebook Share on Linkedin

LAAC patients with major bleeding face worse outcomes, longer lengths of stay

Share on Twitter Share on Facebook Share on Linkedin
IVUS guidance during DES implantation boosts long-term outcomes in new study
The study, published in the American Journal of Cardiology, included data from nearly 20,000 patients treated in 2016 and 2017. 
READ MORE >

In Case You Missed It

Abbott’s TriClip a safe, effective treatment option for severe tricuspid regurgitation

According to the real-world analysis, treatment with TriClip was associated with no major adverse events and a procedural success rate of 100%. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Abbott’s TriClip a safe, effective treatment option for severe tricuspid regurgitation

Share on Twitter Share on Facebook Share on Linkedin
According to the real-world analysis, treatment with TriClip was associated with no major adverse events and a procedural success rate of 100%. 
READ MORE >

TAVR or surgery? Cardiologists say better communication would boost care for patients with structural heart disease

“This survey gives the cardiology community clearer insights into how to enhance the conversations we are already having and align on patient priorities," one specialist said. 

READ MORE >
Large peridevice leaks after left atrial appendage occlusion (LAAO) are incredibly rare and not associated with a greater risk of adverse outcomes, according to new research published in JACC: Clinical Electrophysiology.[1] Smaller residual links are more common, however, and associated with a risk of thromboembolic and bleeding events.
Share on Twitter Share on Facebook Share on Linkedin

TAVR or surgery? Cardiologists say better communication would boost care for patients with structural heart disease

Share on Twitter Share on Facebook Share on Linkedin
Large peridevice leaks after left atrial appendage occlusion (LAAO) are incredibly rare and not associated with a greater risk of adverse outcomes, according to new research published in JACC: Clinical Electrophysiology.[1] Smaller residual links are more common, however, and associated with a risk of thromboembolic and bleeding events.
“This survey gives the cardiology community clearer insights into how to enhance the conversations we are already having and align on patient priorities," one specialist said. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Why new pediatric valve is a breakthrough | FDA's warning after death | Heart surgeon compensation | AI for cardiology questions
Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme